399 related articles for article (PubMed ID: 25840884)
1. Advancing Product Quality: a Summary of the Inaugural FDA/PQRI Conference.
Yu LX; Baker J; Berlam SC; Boam A; Brandreth EJ; Buhse L; Cosgrove T; Doleski D; Ensor L; Famulare J; Ganapathy M; Grampp G; Hussong D; Iser R; Johnston G; Kesisoglou F; Khan M; Kozlowski S; Lacana E; Lee SL; Miller S; Miksinski SP; Moore CM; Mullin T; Raju GK; Raw A; Rosencrance S; Rosolowsky M; Stinavage P; Thomas H; Wesdyk R; Windisch J; Vaithiyalingam S
AAPS J; 2015 Jul; 17(4):1011-8. PubMed ID: 25840884
[TBL] [Abstract][Full Text] [Related]
2. Emerging technology: A key enabler for modernizing pharmaceutical manufacturing and advancing product quality.
O'Connor TF; Yu LX; Lee SL
Int J Pharm; 2016 Jul; 509(1-2):492-498. PubMed ID: 27260134
[TBL] [Abstract][Full Text] [Related]
3. Quality by design (QbD) approaches in current pharmaceutical set-up.
Mishra V; Thakur S; Patil A; Shukla A
Expert Opin Drug Deliv; 2018 Aug; 15(8):737-758. PubMed ID: 30044646
[TBL] [Abstract][Full Text] [Related]
4. Guidelines and strategy of the International Conference of Harmonization (ICH) and its member states to overcome existing impurity control problems for antibiotics in China.
Jiang Y; Xia JP; Yang JH; Zhang ZF; Hu CQ; Zhang ZR
Chin J Nat Med; 2015 Jul; 13(7):498-506. PubMed ID: 26233840
[TBL] [Abstract][Full Text] [Related]
5. Question-based review for pharmaceutical development: An enhanced quality approach.
Simões A; Veiga F; Vitorino C
Eur J Pharm Biopharm; 2024 Feb; 195():114174. PubMed ID: 38160986
[TBL] [Abstract][Full Text] [Related]
6. FDA perspective on specifications for biotechnology products--from IND to PLA.
Murano G
Dev Biol Stand; 1997; 91():3-13. PubMed ID: 9413677
[TBL] [Abstract][Full Text] [Related]
7. Regulatory advice and drug development--a case study in negotiating with regulators.
Seldrup J
Stat Med; 2011 Jun; 30(13):1628-35. PubMed ID: 21365671
[TBL] [Abstract][Full Text] [Related]
8. The Global Bioequivalence Harmonization Initiative: Summary report for EUFEPS international conference.
Chen ML; Blume H; Beuerle G; Davit B; Mehta M; Potthast H; Schug B; Tsang YC; Wedemeyer RS; Weitschies W; Welink J
Eur J Pharm Sci; 2018 Jan; 111():153-157. PubMed ID: 28964950
[TBL] [Abstract][Full Text] [Related]
9. Development of safety qualification thresholds and their use in orally inhaled and nasal drug product evaluation.
Ball D; Blanchard J; Jacobson-Kram D; McClellan RO; McGovern T; Norwood DL; Vogel W; Wolff R; Nagao L
Toxicol Sci; 2007 Jun; 97(2):226-36. PubMed ID: 17369604
[TBL] [Abstract][Full Text] [Related]
10. Priority review drugs approved by the FDA and the EMA: time for international regulatory harmonization of pharmaceuticals?
Alqahtani S; Seoane-Vazquez E; Rodriguez-Monguio R; Eguale T
Pharmacoepidemiol Drug Saf; 2015 Jul; 24(7):709-15. PubMed ID: 26013294
[TBL] [Abstract][Full Text] [Related]
11. Advancing Product Quality: a Summary of the Second FDA/PQRI Conference.
Yu LX; Akseli I; Allen B; Amidon G; Bizjak TG; Boam A; Caulk M; Doleski D; Famulare J; Fisher AC; Furness S; Hasselbalch B; Havel H; Hoag SW; Iser R; Johnson BD; Ju R; Katz P; Lacana E; Lee SL; Lostritto R; McNally G; Mehta M; Mohan G; Nasr M; Nosal R; Oates M; O'Connor T; Polli J; Raju GK; Ramanadham M; Randazzo G; Rosencrance S; Schwendeman A; Selen A; Seo P; Shah V; Sood R; Thien MP; Tong T; Trout BL; Tyner K; Vaithiyalingam S; VanTrieste M; Walsh F; Wesdyk R; Woodcock J; Wu G; Wu L; Yu L; Zezza D
AAPS J; 2016 Mar; 18(2):528-43. PubMed ID: 26860627
[No Abstract] [Full Text] [Related]
12. Integration of Regulatory Guidelines into Protein Drug Product Development.
Wang W
PDA J Pharm Sci Technol; 2016; 70(1):2-11. PubMed ID: 26889052
[TBL] [Abstract][Full Text] [Related]
13. Advancing pharmaceutical quality: An overview of science and research in the U.S. FDA's Office of Pharmaceutical Quality.
Fisher AC; Lee SL; Harris DP; Buhse L; Kozlowski S; Yu L; Kopcha M; Woodcock J
Int J Pharm; 2016 Dec; 515(1-2):390-402. PubMed ID: 27773853
[TBL] [Abstract][Full Text] [Related]
14. US FDA/EMA harmonization of their bioanalytical guidance/guideline and activities of the Global Bioanalytical Consortium.
Garofolo F; Michon J; Leclaire V; Booth B; Lowes S; Viswanathan CT; Welink J; Haidar S; Teixeira Lde S; Tang D; Desilva B
Bioanalysis; 2012 Feb; 4(3):231-6. PubMed ID: 22303826
[TBL] [Abstract][Full Text] [Related]
15. FDA implementation of standards developed by the International Conference on Harmonisation.
Booth PM
Food Drug Law J; 1997; 52(2):203-23. PubMed ID: 10557561
[No Abstract] [Full Text] [Related]
16. Summary report of PQRI Workshop on Nanomaterial in Drug Products: current experience and management of potential risks.
Bartlett JA; Brewster M; Brown P; Cabral-Lilly D; Cruz CN; David R; Eickhoff WM; Haubenreisser S; Jacobs A; Malinoski F; Morefield E; Nalubola R; Prud'homme RK; Sadrieh N; Sayes CM; Shahbazian H; Subbarao N; Tamarkin L; Tyner K; Uppoor R; Whittaker-Caulk M; Zamboni W
AAPS J; 2015 Jan; 17(1):44-64. PubMed ID: 25421459
[TBL] [Abstract][Full Text] [Related]
17. International Conference on Harmonisation; guidance on Q9 Quality Risk Management; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2006 Jun; 71(106):32105-6. PubMed ID: 16795933
[TBL] [Abstract][Full Text] [Related]
18. Considerations and Regulatory Challenges for Innovative Medicines in Expedited Approval Programs: Breakthrough Therapy and Sakigake Designation.
Kajiwara E; Shikano M
Ther Innov Regul Sci; 2020 Jul; 54(4):814-820. PubMed ID: 32557300
[TBL] [Abstract][Full Text] [Related]
19. Best practices for the development, scale-up, and post-approval change control of IR and MR dosage forms in the current quality-by-design paradigm.
Van Buskirk GA; Asotra S; Balducci C; Basu P; DiDonato G; Dorantes A; Eickhoff WM; Ghosh T; González MA; Henry T; Howard M; Kamm J; Laurenz S; MacKenzie R; Mannion R; Noonan PK; Ocheltree T; Pai U; Poska RP; Putnam ML; Raghavan RR; Ruegger C; Sánchez E; Shah VP; Shao ZJ; Somma R; Tammara V; Thombre AG; Thompson B; Timko RJ; Upadrashta S; Vaithiyalingam S;
AAPS PharmSciTech; 2014 Jun; 15(3):665-93. PubMed ID: 24578237
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical product development: A quality by design approach.
Pramod K; Tahir MA; Charoo NA; Ansari SH; Ali J
Int J Pharm Investig; 2016; 6(3):129-38. PubMed ID: 27606256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
